Cholinergic receptors on blood vessel endothelium-
The question is specifically about blood vessel endothelium. I remember that acetylcholine (ACh) acts on endothelial cells to cause vasodilation. This is mediated through muscarinic receptors. But wait, which subtype? Muscarinic receptors have subtypes M1 to M5. The M3 subtype is involved in smooth muscle contraction and gland secretion, but in endothelial cells, it's the M3 receptors that trigger nitric oxide (NO) release. NO then diffuses to the underlying smooth muscle, causing relaxation and vasodilation.
So the correct answer would be that the receptors are muscarinic, specifically M3. Let me check the options. The user didn't list them, but assuming the correct answer is muscarinic. The options might have been something like: A. Nicotinic, B. Muscarinic, C. Alpha-adrenergic, D. Beta-adrenergic. The incorrect options would be nicotinic, which are not found on endothelium, and adrenergic receptors which are different.
Wait, but in some cases, like in the heart, muscarinic M2 receptors are present. But in endothelial cells, M3 is the key. Also, adrenergic receptors are separate from cholinergic. So the wrong options are nicotinic and adrenergic. The clinical pearl here is that cholinergic agonists like ACh cause vasodilation via endothelial M3 receptors, which is why they're used in certain contexts, but can have variable effects if the endothelium is damaged. That's a high-yield fact for exams.
**Core Concept**
Cholinergic receptors on vascular endothelium mediate vasodilation via nitric oxide (NO) release. These are **muscarinic receptors**, specifically **M3 subtype**, which activate Gq proteins to trigger phospholipase C (PLC) and subsequent NO synthase activation.
**Why the Correct Answer is Right**
Acetylcholine (ACh) binds to M3 muscarinic receptors on endothelial cells. This activates PLC, increasing IP3 and DAG, leading to calcium release and NO production. NO diffuses to vascular smooth muscle, activating guanylyl cyclase, elevating cGMP, and causing smooth muscle relaxation and vasodilation. This pathway is critical for endothelium-dependent vasodilation.
**Why Each Wrong Option is Incorrect**
**Option A:** Nicotinic receptors are ionotropic and located at neuromuscular junctions/ganglia, not endothelium.
**Option C:** Alpha-adrenergic receptors mediate vasoconstriction via adrenergic signaling, not cholinergic.
**Option D:** Beta-adrenergic receptors are involved in cardiac stimulation and Ξ²2-mediated bronchodilation, not endothelial cholinergic responses.
**Clinical Pearl / High-Yield Fact**
Endothelial